Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-31
2008-12-30
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S280000, C544S118000, C514S234200
Reexamination Certificate
active
07470697
ABSTRACT:
The present invention provides compounds of the following formula and pharmaceutical compositions that are selective antagonists of A2Badenosine receptors (ARs).These compounds and compositions are useful as pharmaceutical agents.
REFERENCES:
patent: 6545002 (2003-04-01), Linden et al.
patent: 6770651 (2004-08-01), Palle et al.
patent: 6825349 (2004-11-01), Kalla et al.
patent: 2005/0119287 (2005-06-01), Kalla et al.
patent: 2005/0261248 (2005-11-01), Juan et al.
patent: WO03000694 (2003-01-01), None
patent: WO03082873 (2003-01-01), None
Thompson Robert D.
Wang Guoquan
Adenosine Therapeutics, LLC
Coleman Brenda L
Moore Susanna
Williams Mullen Kelly Hollowell
LandOfFree
Pyrrolo[3,2-D] pyrimidines that are selective antagonists of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolo[3,2-D] pyrimidines that are selective antagonists of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo[3,2-D] pyrimidines that are selective antagonists of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4035133